Health Insurance Review & Assessment Service, Seoul, Republic of Korea.
Yonsei University, Seoul, Republic of Korea.
BMJ Open. 2024 Jul 24;14(7):e079232. doi: 10.1136/bmjopen-2023-079232.
We compared the cost-effectiveness of hospital-based treatment and that of community treatment centres (CTCs).
We performed statistical analysis to compare the expenses incurred by COVID-19 patients who received hospital care with those incurred by COVID-19 patients who went to CTCs.
A study was conducted on 411 530 COVID-19 inpatients and 243 329 CTC patients from January 2020 to December 2021.
We calculated the probability of severe disease, hospitalisation period and medical expenses for inpatients and CTC patients. Subsequently, we analysed the cost-effectiveness of CTC compared with hospitalisation.
Comparing medical expenses, CTC patients incurred 2 220 000 KRW on average, which is less than the expenses incurred by hospitalised COVID-19 patients.
The study suggests that using a CTC may be more cost-effective than a hospital service alone.
比较基于医院的治疗与社区治疗中心(CTC)治疗的成本效益。
我们进行了统计分析,比较了接受医院治疗的 COVID-19 患者和前往 CTC 治疗的 COVID-19 患者的费用。
这项研究对 2020 年 1 月至 2021 年 12 月的 411530 名住院 COVID-19 患者和 243329 名 CTC 患者进行了研究。
我们计算了住院患者和 CTC 患者患重病、住院期和医疗费用的概率。随后,我们分析了 CTC 与住院治疗相比的成本效益。
比较医疗费用,平均而言,CTC 患者的费用为 222 万韩元,低于住院 COVID-19 患者的费用。
该研究表明,使用 CTC 可能比单独使用医院服务更具成本效益。